Genetic Syndrome
17
4
5
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
11.8%
2 terminated out of 17 trials
71.4%
-15.1% vs benchmark
12%
2 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (17)
I-TOPS With Patients With Genetic Syndrome SYN-TOPS
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
Study of an Early Parenting Intervention for Children With Genetic Abnormalities and Mental Health Problems
Speech Therapy and Parenting for Early Socio-communicAtive sKills
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients
Perinatal Precision Medicine
NGLY1 Deficiency: A Prospective Natural History Study
Rapid Whole Genome Sequencing Study
Utility of Rapid Whole Genome Sequencing in the NICU: A Pilot Study
Screening of Pulmonary Veino Occlusive Disease in Heterozygous EIF2AK4 Mutation Carriers
Drug-induced Repolarization ECG Changes
Genetic of SportS Induced Endofibrotic Remodeling
New Variants Involved in Taybi-Linder Syndrome